Clinical Trial Update: The SILVER Study: Systolic Hypertension Interaction With Left Ventricular Remodeling [Phase 2]

View source ↗

Summary

The SILVER Phase 2 trial evaluating the interaction between systolic hypertension and left ventricular remodeling has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Left Ventricular Hypertrophy

Snippet

Sponsor: Synvista Therapeutics, Inc | Conditions: Hypertension, Hypertrophy, Left Ventricular | Phase 2 | Status: COMPLETED